Viewing Study NCT06711068


Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2025-12-27 @ 3:13 AM
Study NCT ID: NCT06711068
Status: RECRUITING
Last Update Posted: 2024-12-02
First Post: 2024-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy
Sponsor: Shu Wang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module